|Bid||264.91 x 1300|
|Ask||265.29 x 800|
|Day's range||264.03 - 265.52|
|52-week range||215.90 - 287.32|
|Beta (5Y monthly)||0.59|
|PE ratio (TTM)||47.82|
|Earnings date||08 Nov 2023 - 13 Nov 2023|
|Forward dividend & yield||3.64 (1.37%)|
|Ex-dividend date||07 Sept 2023|
|1y target est||301.67|
BD's (BDX) slew of product launches raises optimism about the stock.
BD's (BDX) latest partnership is likely to accelerate the delivery of innovative personalized therapies to patients who need them the most.
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...